中文

← All funding rounds

Tesorai

United StatesBiology data and toolsSan Diego, United StatesPrivate

Reprocesses the raw files mass spectrometry produces when it measures the proteins in a sample, from new experiments and from published studies, so that protein results can be compared across studies; its products are Tesorai Search (raw-data processing), Tesorai Chat (analyses from plain-language prompts) and Tesorai Trove (a catalogue of curated public proteomics datasets).

Disclosed total$5.3M
Rounds on record1
Latest round$5.3MSeed · 2026-11-18
Last stated valuationNone stated
Investors named8
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date2027$5.3M
Closed round

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-11-18Seed
    Round

    $5.3M

    For: To work with more biopharmaceutical and research customers, build partnerships across the life sciences tools industry and extend the platform beyond proteins to other molecular data.

    Commercial roll-outData generation

    The leads are SiliconANGLE's; TechFundingNews lists all eight investors without naming a lead. Both put total funding at $8M, including an earlier pre-seed. No company release was found and no valuation is reported. The stated use is from TechFundingNews.

    Co-lead · Perplexity FundCo-lead · IQTCo-lead · South Central VenturesNew Stack VenturesNextGen Venture Partnersf7 VenturesVitalStage VenturesZAKA

    On the deal: Joanna Lee Shevelenko (Co-founder and General Partner; spoke for the firm, Perplexity Fund); Tatjana Zabasu Mikuž (Managing Partner; spoke for the firm, South Central Ventures)

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

Its investors also backed

Other companies on this page whose rounds name the same investor.